| Home > Women's Health > |
| Home > Women's Health > |
TUESDAY, Sept. 26 (HealthDay News) -- About one in 10 mammograms comes back abnormal, according to a study by researchers from the University of New Mexico and their colleagues.
Publishing in the October issue of Radiology, the researchers collected data from six National Cancer Institute-funded research sites, for a total of nearly 2.6 million screening exams assessed by 807 radiologists.
The researchers tracked each radiologist's assessment, along with each woman's outcome within 12 months from their screening exam.
Approximately 10 percent of the mammograms yielded abnormal findings. And when a radiologist advised that a biopsy be performed immediately, 34 percent of the biopsy results indicated cancer.
Cancer was ultimately diagnosed in 4.8 out of every 1,000 women.
"Our results show that most radiologists who are reading mammograms are performing well," said lead researcher Dr. Robert Rosenberg, professor of radiology at the University of New Mexico in Albuquerque.
"Mammography, combined with better breast cancer treatments, appears to be helping to decrease the number of deaths from breast cancer," he said.
More information
The National Cancer Institute has more about breast cancer.
|
Top Stories
WEDNESDAY, July 5 (HealthDay News) -- Female survivors of childhood cancer are more li
Most women in the dark about HPVOnly 40 percent had heard of sexually transmitted diseas
Eating red meat may raise breast cancer riskTaking vitamins won't protect against heart
Tighter rules on trendy hormones urgedClaims touting anti-aging 'bioidenticals' are wron
Brazilian model dies from anorexia21-year-old Ana Carolina Reston weighed 88 poundsL'Equ
Amniocentesis doesn't raise miscarriage rateOlder studies overestimated risk, new report
|
|
Related
TUESDAY, Feb. 13 (HealthDay News) -- Switching to newer breast cancer drugs, called ar (HealthDay News) -- While many women take birth control pills without incident, these d MONDAY, Feb. 12 (HealthDay News) -- Extensive genetic analysis has uncovered a gene var MONDAY, Feb. 12 (HealthDay News) -- Postmenopausal breast cancer patients who switch f
FRIDAY, Feb. 9 (HealthDay News) -- A neuropeptide called melanin concentrating hormone
WEDNESDAY, Feb. 7 (HealthDay News) -- A new monoclonal antibody drug produced dramatic
TUESDAY, Feb. 13 (HealthDay News) -- Many patients with moderate to severe chronic psor
FRIDAY, Feb. 2 (HealthDay News) -- People who spend a lot of time behind the wheel may
|

